INNONext Generation Antibody Platforms
3rd - 4th December, 2018
Taj Vivanta, MG Road, Bengaluru, India
Sachdev SidhuProf. and Principal Investigator,
University of Toronto
Date:
Venue:
Philip TagariVice President Research,
Amgen Inc.
www.innofocus.in
INNO 2018, a two-day Antibody Symposium will be held on Monday, 3rd - Tuesday, 4th December 2018, in Bengaluru, India. The Symposium aims to expand our understanding of scientific advancements in Antibody Conjugates with active participation from the Pharma & Biotech industries and the Academia.
The event is an excellent occasion to interact with industry leaders such as Dara Wright & Peter Silvester of Thermo Fisher Scientific, Philip Tagari of Amgen Inc., Kiran Mazumdar Shaw, and Jonathan Hunt from Syngene International, and many others.
Please register to listen to our distinguished speakers discuss the latest innovations and advancement in cutting-edge technologies. We invite scientists to present their research learnings through a poster presentation. Kindly register at the earliest as only limited slots are available.
Keynote Speakers
Sponsors
Event Speakers
Ralf GuentherAssociate Director,
Protein Engineering and Antibody,Merck KGaA.
Andreas MenradVice President, Global Head,
New Biologics Technologies,Merck KGaA.
Abhishek MathurDirector,
Biologics Externalization, Amgen Inc.
Maloy GhoshChief Scientific Officer,Zumutor Biologics Inc.
Irina RybinaPrincipal Scientist,
Biotherapeutic Discovery,Boehringer Ingelheim
Deepa ShankarDirector – R&D
Thermo Fisher Scientific
Dinakar SalunkeDirector,
International Centre for Genetic Engineering and Biotechnology
Sreesha Srinivasa Vice President,
Translational Sciences,Biocon Research Ltd.
Kevin HarveyDirector – Antibody and
Assay Platforms,Thermo Fisher Scientific
Kas SubramanianVice President,Bioinformatics,
Syngene International Ltd.
Saurabh A JoshiAssociate Research
Director, Discovery BiologySyngene
International Ltd.
Chadwick KingDirector,
Antibody discovery,Amgen Inc.
Day 1: Monday, 3rd December, 2018
8:00-8:45Registration and Refreshment
9:45-10:30Philip Tagari - Keynote speaker
8:45-9:45Welcome and Opening RemarksKiran Mazumdar Shaw, Jonathan Hunt, Philip Tagari, Peter Silvester and Dara Wright
Inducing or breaking tolerance for difficult-to-make antibodies
11:00-11:40Saurabh A Joshi
11:40-12:20
Addressing Antibody Reproducibility – ABfinity and beyond!
Transgenic animals and Yeast Surface Display – a Versatile Combination for Selection and
Engineering of Mono- and Bispecific Antibodies
Addressing New Challenges in Therapeutic Antibody Discovery with Technology Innovation
13:30-14:10
14:10-14:50
Deepa Shankar
15:00-16:00Refreshment and Poster Session
16:40-17:15Panel Discussion: Saurabh Joshi, Ralf Guenther, Maloy Ghosh, Deepa Shankar and Chadwick KingModerator: Sachdev Sidhu
Ralf Guenther
Human antibody library development for therapeutic monoclonal antibody products
16:00-16:40Maloy Ghosh
10:30-11:00
The Past, Present & Future of Antibody-based Therapeutics
Networking, Refreshment Break & Poster set-up
Chadwick King
12:30-13:30Networking Lunch
Day 2: Tuesday, 4th December, 2018
11:50-12:30Abhishek Mathur
13:30-14:10
14:40-15:10
8.30-9:10
14:10-14:40Kas Subramanian
8:00-8:30
12:30-13:30Networking Lunch
10:00-10:30Networking, Refreshment Break & Poster set-up
11:10-11:50
Construct Design, Expression and Purification of High Quality Reagents for Antibody Generation and Screening
Irina Rybina
Impact of Monoclonal IgG Aggregates on In vitro Bioactivity Assessment
10:30-11:10
Advanced Verification: What Do We mean by Antibody Specificity?
Kevin Harvey
New paradigms of antibody specificity at molecular level
Using QSP to optimize bispecific antibody properties for immunotherapeutic efficacy
15:10-16:10Refreshment and Poster Session
16:45-17:15Awards and closure ceremony of the symposium
Dinakar Salunke
Targeting the tumour and the microenvironment with a bi-functional
monoclonal antibody
Sreesha Srinivas
16:10-16:45Panel Discussion: Andreas, Irina, Abhishek,
Dinakar, Kevin, Kas and SreeshaModerator: Jayashree Aiyar
Refreshment
From Systems Biology to Systems BiologicsSachdev Sidhu - Keynote speaker
Therapeutic Antibodies: Current State and Future Trends
9:10-10:00Andreas Menrad
Poster Presentaion
We invite scientists and students to present their scientific poster and share their research findings on Antibody Conjugates.
Poster size – 3ft x 4ft – portrait orientationShortlisting of posters will be made by the Technical CommitteeShortlisted presenters will be notified by emailEach poster session presenter will be provided with a poster board area and mounting pins. The board will indicate the poster number in the upper right or left corner. Presenters are responsible for installing their posters the morning of their presentation and removing them at the end of the session.Poster presenters to stand next to their poster during the session to exhibit and explain their work to the symposium attendeesFor queries please contact: [email protected]
Guidelines for Poster Submission
Amgen Inc. focuses on areas of high unmet medical need and leverages its expertise to strive for solutions that improve health outcomes and dramatically improve people's lives. A biotechnology pioneer since 1980, Amgen Inc. has grown to be one of the world's leading independent biotechnology companies, has reached millions of patients around the world and is developing a pipeline of medicines with breakaway potential.For more details, visit www.amgen.com.
Syngene International Ltd., an innovation-focused global discovery, development and manufacturing organisation offers integrated services to the pharmaceutical, biotechnology, nutrition, animal health, consumer goods and speciality chemicals industries across the world. Syngene’s clientele includes market leaders such as Bristol-Myers Squibb, Baxter, Amgen Inc. , GSK, Zoetis, Merck KGaA and Herbalife. Its innovative culture is driven by a strong team of over 3,500 scientists working with clients around the world to improve R&D productivity while reducing development time and cost.For more details, visit www.syngeneintl.com.
Thermo Fisher Scientific Inc. is the world leader in serving science, with revenues of more than $20 billion and approximately 70,000 employees globally. Our mission is to enable our customers to make the world healthier, cleaner and safer. We help our customers accelerate life sciences research, solve complex analytical challenges, improve patient diagnostics, deliver medicines to market and increase laboratory productivity. Through our premier brands – Thermo Scientific, Applied Biosystems, Invitrogen, Fisher Scientific and Unity Lab Services – we offer an unmatched combination of innovative technologies, purchasing convenience and comprehensive services. For more information, please visit www.thermofisher.com.
Sponsors